Clinical Trial Update: Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract for Local Allergic Rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Local Allergic Rhinitis

Drugs mentioned

• House dust mite extract (Dermatophagoides pteronyssinus) (Dermatophagoides pteronyssinus extract)

Snippet

Sponsor: Miguel Blanca Gomez | Conditions: Local Allergic Rhinitis | Phase 2 | Status: COMPLETED